Diabetes

Certain Social, Behavioral Factors Associated With Diabetes and Hypertension Onset
Select behavioral and social risk factors were correlated with early onset of hypertension and diabetes, a prospective cohort study found. Source: Certain Social, Behavioral Factors Read more
T2D Predicts Progression in NAFLD/NASH
Type 2 diabetes was found to be a strong independent predictor of life-threatening liver outcomes in patients diagnosed with nonalcoholic fatty liver disease (NAFLD) and its more advanced Read more
Exercise should be emphasized in patients with dyslipidemia
Given all of the recent guidelines on physical activity and CVD prevention, health care providers should focus on recommending exercise for patients with dyslipidemia to decrease their LDL, Read more
Certain Social, Behavioral Factors Associated With Diabetes and Hypertension Onset
Education and exercise may determine early start of diabetes and hypertension Source: Certain Social, Behavioral Factors Associated With Diabetes and Hypertension Read more
Diabetes self-management strategies decreased fall-risk, injuries in patients with CKD
Engaging in regular self-management of diabetes may decrease the risk for both falls and fall-related injuries in patients with diabetes and CKD, according to a poster presented at the Read more
Second-Line Diabetes Drugs and Cardiovascular Risks
Cardiovascular disease is the leading cause of morbidity and mortality in type 2 diabetes. Metformin is used widely as first-line therapy and may have cardiovascular benefits, but if Read more
Providers, regulators explore type 2 therapies for type 1 diabetes
For most children and adults with type 1 diabetes, day-to-day disease management remains difficult despite improvements in insulin formulations and delivery and advancements in diabetes Read more
Is insulin pump therapy superior to multiple daily injections in type 1 diabetes?
Endocrine Today | PoinTAll pumps on the market offer several useful features for people with type 1 diabetes. These include multiple basal rate options, square- and dual-wave bolus Read more
Medication Nonadherence Common in Patients With T2DM
Routine urine samples can be used to test for medication adherence in patients with type 2 diabetes, according to a study published in the June issue of Diabetes Care. Source: Medication Read more
How fasting may prevent obesity-related insulin resistance
Scientists conducted a small study of the 30-day fasting practice of Ramadan and found evidence of significant metabolic benefits. Source: How fasting may prevent obesity-related insulin Read more
Multiple pregnancies increase diabetes risk in postmenopausal women
Postmenopausal women reporting a history of at least four pregnancies were 28% more likely to develop diabetes when compared with women who reported two or three pregnancies, according to Read more
Abnormal sleep patterns raise HbA1c levels in prediabetes, untreated type 2 diabetes
Adults with prediabetes or untreated type 2 diabetes who sleep fewer than 5 hours or more than 8 hours per night tend to have higher blood glucose levels than those who sleep between 7 and Read more
Type 1 Diabetes Has Early Adverse Effects on Bone Mineral Density 
For children with type 1 diabetes(T1D), adverse effects on bone mineral density (BMD) begin early in the course of disease, according to study results published in The Journal of Clinical Read more
Lifestyle intervention leads to reduced medication in new type 2 diabetes study
A Dutch lifestyle intervention has helped people with type 2 diabetes reduce their medication doses over a six-month period. Compared to before the study, average HbA1c levels dropped by 5 Read more
Glycemic control, disease duration predict fracture risk in type 1 diabetes
Long disease duration and an HbA1c of at least 7.9% are independent risk factors for sustaining multiple fractures among adults with type 1 diabetes, according to findings from a Read more
HbA1c, insulin use predict real-world response to GLP-1 receptor agonists in type 2 diabetes
A patient’s response to GLP-1 receptor agonist therapy in type 2 diabetes depends on several pretreatment characteristics, including baseline HbA1c, diabetes duration, age and use of Read more